Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Idiopathic hyperaldosteronism (E26.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Conn syndrome (E26.000x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary hyperaldosteronism (low-renin aldosteronism) (E26.000x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduct
Liddle syndrome (E26.000x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary hyperaldosteronism (E26.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Male adrenogenital precocious puberty (E25.903) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Adrenogenital syndrome (E25.902) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Adrenal hyperplasia with female virilization (E25.901) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Adrenogenital disorder (E25.900) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Female adrenogenital pseudohermaphroditism (E25.802) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being c
Pseudoprecocious puberty (E25.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other adrenogenital disorders (E25.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
21-hydroxylase deficiency (E25.003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
17-alpha-hydroxylase deficiency (E25.002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
11-beta-hydroxylase deficiency (E25.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Congenital adrenal hypoplasia (E25.000x015) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
21-hydroxylase deficiency (E25.000x014) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
21-hydroxylase deficiency (E25.000x013) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
17-hydroxylase deficiency (E25.000x012) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
11-hydroxylase deficiency (E25.000x011) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|